Sohair Salem

Sohair Salem

Auto-generated profile, based on publicly available information

Sohair Salem

Molecular Genetics and Enzymology Department, National Research Centre, Giza, Egypt

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Behavioural Brain Research
Verified
Journal Article
Closed access
NENora N. Esmaiel
Nora N. Esmaiel
EAEngy A. Ashaat
Engy A. Ashaat
RMRehab Mosaad
Rehab Mosaad
AFAlaaeldin Fayez
Alaaeldin Fayez
MIMona Ibrahim
Mona Ibrahim
SISamira Ismail
Samira Ismail

7 December 2023 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
SYShaymaa M. M. Yahya
Shaymaa M. M. Yahya
Heba Kamal Nabih HanafiHeba Kamal Nabih Hanafi
Heba Kamal Nabih Hanafi
GEGhada H. Elsayed
Ghada H. Elsayed
SMShimaa Ibrahim Abdelmenym Mohamed
Shimaa Ibrahim Abdelmenym Mohamed
AEAsmaa M. Elfiky
Asmaa M. Elfiky
SSSohair M. Salem
Sohair M. Salem
Purpose: Breast cancer is one of the leading types of cancer diagnosed in women. Despite the improvements in chemotherapeutic cure strategies, drug resistance is still an obstacle leading to disease aggressiveness. The small non-coding RNA molecules, miRNAs, have been implicated recently to be involved as regulators of gene expression through the silencing of mRNA targets that contributed to several cellular processes related to cancer metastasis. Hence, the present study aimed to investigate the beneficial role and mechanism of miRNA-34a-based gene therapy as a novel approach for conquering drug resistance mediated by ATP-binding cassette (ABC) transporters in breast cancer cells, besides exploring the associated invasive behaviors. Material and Methods: Bioinformatics tools were used to predict miRNA ABC transporter targets by tracking the ABC transporter pathway. After the establishment of drug-resistant breast cancer MCF-7 and MDA-MB-231 sublines, cells were transfected with the mimic or inhibitor of miRNA-34a-5p. The quantitative expression of genes involved in drug resistance was performed by QRT-PCR, and the exact ABC transporter target specification interaction was confirmed by dual-luciferase reporter assay. Furthermore, flow cytometric analysis was utilized to determine the ability of miRNA-34a-treated cells against doxorubicin uptake and accumulation in cell cycle phases. The spreading capability was examined by colony formation, migration, and wound healing assays. The apoptotic activity was estimated as well. Results: Our findings firstly discovered the mechanism of miRNA-34a-5p restoration as an anti-drug-resistant molecule that highly significantly attenuates the expression of ABCC1 via the direct targeting of its 3′- untranslated regions in resistant breast cancer cell lines, with a significant increase of doxorubicin influx by MDA-MB-231/Dox-resistant cells. Additionally, the current data validated a significant reduction of metastatic potentials upon miRNA-34a-5p upregulation in both types of breast cancer-resistant cells. Conclusion: The ectopic expression of miRNA-34a ameliorates the acquired drug resistance and the migration properties that may eventually lead to improved clinical strategies and outcomes for breast cancer patients. Additionally, miRNA-34a could be monitored as a diagnostic/prognostic biomarker for resistant conditions.

1 January 2013 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
ASAhmed M. Salem
Ahmed M. Salem
SISamira Ismail
Samira Ismail
WZWaheba A. Zarouk
Waheba A. Zarouk
OBOlwya Abdul Baky
Olwya Abdul Baky
ASAhmed A. Sayed
Ahmed A. Sayed
SSSohair Salem
Sohair Salem
Autism is a neurodevelopmental disorder with indisputable evidence for a genetic component. This work studied the association of autism with genetic variations in neurotransmitter‐related genes, including MAOA uVNTR, MAOB rs1799836, and DRD2 TaqI A in 53 autistic patients and 30 healthy individuals. The study also analyzed sequence variations of miR-431 and miR-21. MAOA uVNTR was genotyped by PCR, MAOB and DRD2 polymorphisms were analyzed by PCR‐based RFLP, and miR-431 and miR-21 were sequenced. Low expressing allele of MAOA uVNTR was frequently higher in female patients compared to that in controls (OR = 2.25). MAOB G allele frequency was more significantly increased in autistic patients than in controls (P < 0.001 for both males and females). DRD2 A1+ genotype increased autism risk (OR = 5.1). Severity of autism tends to be slightly affected by MAOA/B genotype. Plasma MAOB activity was significantly reduced in G than in A allele carrying males. There was no significant difference in patients and maternal plasma MAOA/B activity compared to controls. Neither mutations nor SNPs in miR-431 and miR-21 were found among studied patients. This study threw light on some neurotransmitter‐related genes suggesting their potential role in Autism pathogenesis that warrants further studies and much consideration.

1 October 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SSSohair M. Salem
Sohair M. Salem
AHAhmed Ragab Hamed
Ahmed Ragab Hamed
RMRehab M. Mosaad
Rehab M. Mosaad

8 January 2016 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
HRHanaa M. Rady
Hanaa M. Rady
AHAmal Z. Hassan
Amal Z. Hassan
SSSohair M. Salem
Sohair M. Salem
TMTahia K. Mohamed
Tahia K. Mohamed
NENora N. Esmaiel
Nora N. Esmaiel
FFFayez K. Fouda
Fayez K. Fouda

4 April 2023 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Open access
PDF file
SSSohair Salem
Sohair Salem
EAEngy Ashaat
Engy Ashaat
Autism is associated with genomic instability, which is regulated by telomere length (TL) and index of global methylation (LINE-1). This study will determine relative TL (RTL) and LINE-1 methylation percentage for 69 patients and 33 control subjects to evaluate their potential role as biomarkers for autism. The results displayed a significant decrease of both RTL and LINE-1 methylation in autistic cases relative to controls (P < 0.001). Analysis of receiver operating characteristics curve revealed that both of RTL and LINE-1 methylation percentage have the ability to serve as autism biomarkers (area under the curve = 0.817 and 0.889, respectively). The statistical analysis revealed positive correlation between the two biomarkers (correlation coefficient = 0.439 and P < 0.001).